Search

everythinglearnresearchcommunity

for

Search:↓

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

Selenium can be toxic to animals, causing serious health issues, especially in horses.

The polyherbal hair oil effectively reduces dandruff and promotes hair growth.

Improving oral hygiene and quitting smoking can resolve black hairy tongue.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Fetal cells could improve skin repair with minimal scarring and are a potential ready-to-use solution for tissue engineering.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Cedrol from Platycladus orientalis leaves may promote hair growth effectively, especially in female mice.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

New treatments are available for managing ingrown hair inflammation.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Platelet-rich plasma is beneficial in various plastic surgery applications, but more research is needed to standardize its use.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

The Edwardian medical campaign linked maternal drinking to infant mortality and national decline, influencing hygiene education and leading to a ban on children under 14 from pubs.

Elephantopus scaber has many health benefits, including antibacterial, antifungal, anticancer, and antioxidant properties.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.